Ignite Creation Date:
2024-05-06 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03464890
Status:
COMPLETED
Last Update Posted:
2018-03-27
First Post:
2018-03-08
Brief Title:
Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area
Sponsor:
Derming SRL
Organization:
Derming SRL
Study Overview
Official Title:
Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Open clinical study to evaluate the soothing and re-epithelizing activity of a single application of two cometic formulations P926 - LICHTENA DermAD CREMA VISO and P927 - LICHTENA DermAD CREMA CORPO on experimentally induced erythema by repeated tape stripping on the forearm volar surface of 20 healthy volunteers
Study products activity was assessed in comparison to placebo P926P - LICHTENA DermAD CREMA VISO - PLACEBO and versus untreated control area
Study products activity was assessed in comparison to placebo P926P - LICHTENA DermAD CREMA VISO - PLACEBO and versus untreated control area
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None